|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pakzad R, Mohammadian-Hafshejani A,
Ghoncheh M, Pakzad I and Salehiniya H: The incidence and mortality
of lung cancer and their relationship to development in Asia.
Transl Lung Cancer Res. 4:763–774. 2015.PubMed/NCBI
|
|
3
|
Amini A, Byers LA, Welsh JW and Komaki RU:
Progress in the management of limited-stage small cell lung cancer.
Cancer. 120:790–798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Ao X, Yu W, Zhang Y and Wang J:
Biogenesis, functions, and clinical implications of circular RNAs
in non-small cell lung cancer. Mol Ther Nucleic Acids. 27:50–72.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Cancer Society: Cancer Facts
& Figures 2024. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.htmlOctober
22–2024
|
|
6
|
Liang Y, Xie L, Liu K, Cao Y, Dai X, Wang
X, Lu J, Zhang X and Li X: Bergapten: A review of its pharmacology,
pharmacokinetics, and toxicity. Phytother Res. 35:6131–6147. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo TT, Lu Y, Yan SK, Xiao X, Rong XL and
Guo J: Network pharmacology in research of chinese medicine
formula: Methodology, application and prospective. Chin J Integr
Med. 26:72–80. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Z, Chen B, Chen S, Lin M, Chen Y, Jin
S, Chen W and Zhang Y: Applications of network pharmacology in
traditional Chinese medicine research. Evid Based Complement
Alternat Med. 2020:16469052020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng Y, Wang Y, Zhou C, Mei W and Zeng C:
PI3K/Akt/mTOR pathway and its role in cancer therapeutics: Are we
making headway? Front Oncol. 12:8191282022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eberhardt J, Santos-Martins D, Tillack AF
and Forli S: AutoDock Vina 1.2.0: New docking methods, expanded
force field, and python bindings. J Chem Inf Model. 61:3891–3898.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gautschi O, Ratschiller D, Gugger M,
Betticher DC and Heighway J: Cyclin D1 in non-small cell lung
cancer: A key driver of malignant transformation. Lung Cancer.
55:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siegfried JM, Hershberger PA and Stabile
LP: Estrogen receptor signaling in lung cancer. Semin Oncol.
36:524–531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alves M, Borges DP, Kimberly A, Martins
Neto F, Oliveira AC, de Sousa JC, Nogueira CD, Carneiro BA and
Tavora F: Glycogen synthase kinase-3 beta expression correlates
with worse overall survival in non-small cell lung cancer-A
clinicopathological series. Front Oncol. 11:6210502021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Moretti L, Giacalone NJ, Schleicher
S, Speirs CK, Carbone DP and Lu B: Inhibition of JAK2 signaling by
TG101209 enhances radiotherapy in lung cancer models. J Thorac
Oncol. 6:699–706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen W, Li Z, Bai L and Lin Y: NF-kappaB
in lung cancer, a carcinogenesis mediator and a prevention and
therapy target. Front Biosci (Landmark Ed). 16:1172–1185. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Wang Y, Li J, Li J and Che G:
Clinical significance of PIK3CA gene in non-small-cell lung cancer:
A systematic review and meta-analysis. Biomed Res Int.
2020:36082412020.PubMed/NCBI
|
|
18
|
Tong X, Tanino R, Sun R, Tsubata Y,
Okimoto T, Takechi M and Isobe T: Protein tyrosine kinase 2: A
novel therapeutic target to overcome acquired EGFR-TKI resistance
in non-small cell lung cancer. Respir Res. 20:2702019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoden B, DeRubeis D, Martinez-Moczygemba
M, Ramos KS and Zhang D: Understanding the role of Toll-like
receptors in lung cancer immunity and immunotherapy. Front Immunol.
13:10334832022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Payea MJ, Anerillas C, Tharakan R and
Gorospe M: Translational control during cellular senescence. Mol
Cell Biol. 41:e00512–20. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jo H, Mondal S, Tan D, Nagata E, Takizawa
S, Sharma AK, Hou Q, Shanmugasundaram K, Prasad A, Tung JK, et al:
Small molecule-induced cytosolic activation of protein kinase Akt
rescues ischemia-elicited neuronal death. Proc Natl Acad Sci USA.
109:10581–10586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maidarti M, Anderson RA and Telfer EE:
Crosstalk between PTEN/PI3K/Akt signalling and DNA damage in the
oocyte: Implications for primordial follicle activation, oocyte
quality and ageing. Cells. 9:2002020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oh SJ, Erb HHH, Hobisch A, Santer FR and
Culig Z: Sorafenib decreases proliferation and induces apoptosis of
prostate cancer cells by inhibition of the androgen receptor and
Akt signaling pathways. Endocr Relat Cancer. 19:305–319. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reuter S, Eifes S, Dicato M, Aggarwal BB
and Diederich M: Modulation of anti-apoptotic and survival pathways
by curcumin as a strategy to induce apoptosis in cancer cells.
Biochem Pharmacol. 76:1340–1351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kowald A, Passos JF and Kirkwood TBL: On
the evolution of cellular senescence. Aging Cell. 19:e132702020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wiley CD and Campisi J: The metabolic
roots of senescence: Mechanisms and opportunities for intervention.
Nat Metab. 3:1290–1301. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calcinotto A, Kohli J, Zagato E,
Pellegrini L, Demaria M and Alimonti A: Cellular senescence: Aging,
cancer, and injury. Physiol Rev. 99:1047–1078. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salama R, Sadaie M, Hoare M and Narita M:
Cellular senescence and its effector programs. Genes Dev.
28:99–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tesei A, Arienti C, Bossi G, Santi S, De
Santis I, Bevilacqua A, Zanoni M, Pignatta S, Cortesi M, Zamagni A,
et al: TP53 drives abscopal effect by secretion of
senescence-associated molecular signals in non-small cell lung
cancer. J Exp Clin Cancer Res. 40:892021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv FZ, Wang JL, Wu Y, Chen HF and Shen XY:
Knockdown of MMP12 inhibits the growth and invasion of lung
adenocarcinoma cells. Int J Immunopathol Pharmacol. 28:77–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu C, Yang L, Xu H, Zheng S, Wang Z, Wang
S, Yang Y, Zhang S, Feng X, Sun N, et al: Systematic analysis of
IL-6 as a predictive biomarker and desensitizer of immunotherapy
responses in patients with non-small cell lung cancer. BMC Med.
20:1872022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li C, Zheng H, Xiong J, Huang Y, Li H, Jin
H, Ai S, Wang Y, Su T, Sun G, et al: miR-596-3p suppresses brain
metastasis of non-small cell lung cancer by modulating YAP1 and
IL-8. Cell Death Dis. 13:6992022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hashimoto K, Nishimura S and Akagi M: Lung
adenocarcinoma presenting as a soft tissue metastasis to the
shoulder: A case report. Medicina (Kaunas). 57:1812021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Qin Q and Cong H: Research progress
on the relationship between mitochondrial deoxyguanosine kinase and
apoptosis and autophagy in lung adenocarcinoma cells. Cancer
Insight. 1:53–62. 2022. View Article : Google Scholar
|
